403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Avai Bio Inc
(MENAFN- Baystreet) 10:59 AM EST - Avai Bio Inc: Announced, together with its joint venture partner and global biotechnology company Austrianova, the successful completion of comprehensive adventitious agent and viral testing of its GMP Master Cell Bank, from which its Working Cell Bank was recently established. With the testing completed and the WCB now successfully established, Avaí Bio and Austrianova have completed an important milestone in the development of the Company's genetically modified a-Klotho-producing cell line. Avai Bio Inc
shares O are trading off $0.03 at $0.11.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment